Mitsui launches QIDO hybrid platform for drug and material research

Mitsui & Co., Ltd., together with Quantum Simulation Technologies, Inc. QSimulate (CEO: Toru Shiozaki), a computational chemistry software company, and Quantinuum (CEO: Rajeeb Hazra), a leader in quantum computing, have created a quantum-classical hybrid platform called QIDO (Quantum-Integrated Discovery Orchestrator). The platform will be available starting August 19, 2025.

Quantum computing will change areas like drug discovery, materials science, and chemistry. It will allow for more precise molecular design. Challenges still exist, such as the technology’s maturity, a lack of specialized talent, and high costs for implementation. Effective digital methods for materials development must link tiny quantum actions to bigger product performance. This process is complex and requires advanced computational chemistry, quantum innovation, and AI. Companies can gain a big edge by using these technologies. They simulate and analyze material properties and chemical reactions in virtual settings.

QIDO tackles these challenges by improving material design and reaction analysis. This boosts precision and efficiency, which helps cut R&D lead times and reduce costs. The platform merges QSimulate’s classical software, QSP Reaction, with 量子’s quantum tool, InQuanto. This hybrid framework combines practical classical simulations with advanced quantum calculations. This setup allows for high-level molecular simulations.

こちらもお読みください： Eisai’s Insomnia drug DAYVIGO approved for Use in China

The workflow starts with QSP Reaction analyzing chemical reactions in detail. Then, the results go to InQuanto for easier quantum computation. This approach makes advanced quantum chemistry techniques easier to use. Traditionally, these methods needed specialized expertise. Now, more researchers can access them. QIDO has an easy-to-use interface and automated analysis tools. Users can pick the best methods and research more efficiently. The platform is cloud-based, allowing flexible trial analyses on various research themes. This speeds up the practical use of quantum technologies.

Potential applications for QIDO include chemical reaction pathfinding, excited-state calculations, drug discovery, catalyst and enzyme design, sustainable material development, and energy technologies. Mitsui plans to boost the platform’s features for specific areas like battery technology and biotechnology.

三井物産 uses QIDO to meet rising market needs in drug discovery, materials, and chemistry. It also promotes quantum computing to tackle important industrial challenges.